Day: August 15, 2022
Focused on advancement of lead programs, exebacase and CF-370, into new clinical studies
YONKERS, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced financial results and business updates for the second quarter ended June 30, 2022.
“Despite the recent setback from the interim futility analysis of our Phase 3 DISRUPT superiority study of intravenous (IV) exebacase, we continue to advance our lead programs toward new clinical studies. We expect to file with regulatory authorities later this year to initiate a study of intra-articular exebacase in...
Free Flow, Inc. Announces Heavy Melting Scrap Metal Purchase Agreement Valued at $14 Million
Written by Customer Service on . Posted in Public Companies.
KING GEORGE, VA, Aug. 15, 2022 (GLOBE NEWSWIRE) — Free Flow, Inc. (OTCQB: FFLO), is pleased to announce a new heavy melting scrap metal purchasing agreement valued at $14 million. The purchasing agreement is expected to involve a total of approximately 45,000 metric tons.
Mr. Sabir Saleem, Free Flow, Inc. Chief Executive Officer stated, “Adding a new scrap metal purchasing agreement worth $14 million in contract value is another significant milestone for Free Flow as we continue to enhance shareholder value.”
The contracted client is a major international supplier of commodities to industrial consumers, and its management possess over a 30-year history in bulk commodity trading and shipping.
Pricing for the scrap metal will be determined by the international published price index as reported by COMEX (Commodity Exchange Inc.)...
AS Tallinna Vesi submitted an application to the Competition Authority to adjust the price for water services
Written by Customer Service on . Posted in Public Companies.
AS Tallinna Vesi submitted an application to the Competition Authority on 15/08/2022 to increase the price for water services by 26 cents per cubic metre on average.
According to Aleksandr Timofejev, Chairman of the Board of Tallinna Vesi, the price of electricity has increased approximately 3.5 times since the current price for water services provided by the Company was applied. “With inflation of nearly 23% and in a situation where high electricity prices affect all sectors, the current price for water services no longer covers justified costs. The electricity accounts for about 25% of our operational costs and in order to ensure the high quality and consistency of the service, we must apply to the Competition Authority for an increase in the price for water services to cover the costs.”
The price for water services includes the water...
Mativ to Participate in Sidoti’s August 2022 Micro-Cap Virtual Conference
Written by Customer Service on . Posted in Public Companies.
Alpharetta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Mativ Holdings, Inc. (“MATV” or the “Company”) (NYSE: MATV) announced today that the Company is scheduled to participate in the Sidoti August 2022 Micro-Cap Virtual Conference.
The presentation will be on Wednesday, August 17, beginning at 8:30 am E.T. The live webcast of the presentation can be accessed using the following link https://sidoti.zoom.us/webinar/register/WN_Cwr13gChR_-5PPFcpC8Jcw or through the Company’s investor relations website at https://ir.mativ.com.
About Mativ
Mativ Holdings, Inc. is a global leader in specialty materials headquartered in Alpharetta, Georgia. The Company offers a wide range of critical components and engineered solutions to solve our customers’ most complex challenges. With over 7,500 employees worldwide, we manufacture on...
OMNIQ Reports Record 6 months results. $50M in revenue for 6 months ended June 30, 2022. Second Quarter $24.2M Revenue up 85% over Q2 2021.
Written by Customer Service on . Posted in Public Companies.
SALT LAKE CITY, Aug. 15, 2022 (GLOBE NEWSWIRE) — OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced its financial results for the three months and six months ended June 30 , 2022.
OMNIQ’s 2022 continuous momentum:54% growth in 6 month Revenue marks an all-time record of over $50 Million.
104% growth in 6 Month Gross Profit up to a record of over $12M.
85% Growth in Q2 Revenue compared to Q2 2021.
81% increase in Q2 Gross Profit compared to Q2 2021.
Gross margin for the 6 months up to 24% compared to 18% in the same period of 2021.
Q2 marks a breakthrough in penetrating the retail and restaurant markets with the Company’s AI integrated solution.
OMNIQ’s Q Shield AI based law enforcement solution offered to municipalities is experiencing positive...
NeoGames’ BtoBet Agrees to Multi-Channel Sportsbook Partnership with SOJOGO, the Lottery Operator in Mozambique
Written by Customer Service on . Posted in Public Companies.
Will be providing SOJOGO, the Santa Casa da Misericórdia de Lisboa, ELAM and other 9 Mozambican Associations partnership with its proprietary sportsbook solution
LUXEMBOURG, Aug. 15, 2022 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) subsidiary BtoBet, a leading sports betting supplier, has announced a multi-year partnership agreement with SOJOGO and Santa Casa Global, the global arm of the Portuguese National Lottery Santa Casa da Misericórdia de Lisboa.
Through this partnership BtoBet will be providing SOJOGO with its proprietary sportsbook offering for both its online operations and retail network.
Alcinda Santiago, General Director of SOJOGO, said: “In BtoBet we have found a sportsbook platform partner that matches our own ambitions and focus on gaining a leadership role in its market.
Francisco Pessoa e Costa, Executive...
Rigetti Computing Announces Upcoming Investor Conference Schedule
Written by Customer Service on . Posted in Public Companies.
BERKELEY, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (“Rigetti” or the “Company”) (Nasdaq: RGTI), a pioneer in full-stack quantum-classical computing, today announced its investor conference schedule for August and September 2022. During the period, management will take one-on-one meetings at the Needham & Co. Semiconductor, Jefferies Semiconductor, and Deutsche Bank Technology investor conferences. Chad Rigetti, founder and CEO, also will participate in a fireside chat at the Deutsche Bank Technology conference.
Further information regarding these events is included below.
3rd Annual Needham Virtual Semiconductor and SemiCap 1×1 ConferenceChad Rigetti, founder and CEO
Wednesday, August 24, 2022, to Thursday, August 25, 2022Jefferies Semis, IT Hardware & Comm Infrastructure...
SciSparc Signs a Non- Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal
Written by Customer Service on . Posted in Mergers And Acquisitions.
The Letter of Intent contemplates the purchasing of a brand, trademark and Amazon.com seller account, a management agreement, a U.S. distribution agreement and an option to expand to new territories
TEL AVIV, Israel, Aug. 15, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it has signed a non-binding letter of intent (“LOI”) with Merhavit M.R.M Holding and Management Ltd (“M.R.M”), to acquire from it its rights to purchase, a top-seller Amazon.com account and American food supplements and cosmetics brand and trademark (the “Brand”).
The Brand offers dozens of GMP (Good Manufacturing Practice) manufactured hemp-based, U.S. made, top-ranked...
Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Phase 2 SIGNAL-HD Study Published in Nature Medicine
Patient enrollment continues in the Phase 1/2a SIGNAL-AD Alzheimer’s study
ROCHESTER, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced financial results for the second quarter ended June 30, 2022 and provided a corporate update on key events since April, 2022 (the last 5 months).
“Vaccinex has made excellent progress this year in its clinical programs to evaluate the potential use of our proprietary SEMA4D inhibitor, pepinemab,...
AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
AIM CEO Thomas K. Equels
AIM CEO Thomas K. Equels– On track to commence Phase 2 study for lead program evaluating Ampligen® (rintatolimod) for the treatment of pancreatic cancer in Q3 2022
– Well-positioned to achieve multiple near-term clinical and regulatory value-driving milestones
– Capital position expected to fund company through end of 2023
OCALA, Fla., Aug. 15, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today reported its financial results for the second quarter 2022 and provided a business update.
“As the second quarter results demonstrate, we believe we...